What is the mesna, doxorubicin, ifosfamide, and dacarbazine regimen for the treatment of metastatic soft tissue sarcoma?

Updated: Apr 29, 2019
  • Author: from Memorial Sloan-Kettering - Mrinal M Gounder, MD; Chief Editor: Edwin Choy, MD, PhD  more...
  • Print
Answer

Answer

Mesna 2.5 g/m2/day IV continuous infusion on days 1-4 plus

Doxorubicin 20 mg/m2/day IV continuous infusion on days 1-3 plus

Ifosfamide 2.5 g/m2/day IV continuous infusion on days 1-3 plus

Dacarbazine 300 mg/m2/day IV continuous infusion on days 1-3

Repeat every 3 wk [25]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!